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Pneumonia occurring outside of the hospital setting has traditionally been categorized as communityacquired pneumonia (CAP). However, when pneumonia is associated with health care risk factors (prior
hospitalization, dialysis, residing in a nursing home, immunocompromised state), it is now more appropriately
classified as a health care-associated pneumonia (HCAP). The relative incidences of CAP and HCAP among
patients requiring hospital admission is not well described. The objective of this retrospective cohort study,
involving 639 patients with culture-positive CAP and HCAP admitted between 1 January 2003 and 31 December 2005, was to characterize the incidences, microbiology, and treatment patterns for CAP and HCAP among
patients requiring hospital admission. HCAP was more common than CAP (67.4% versus 32.6%). The most
common pathogens identified overall included methicillin-resistant Staphylococcus aureus (24.6%), Streptococcus pneumoniae (20.3%), Pseudomonas aeruginosa (18.8%), methicillin-sensitive Staphylococcus aureus (13.8%),
and Haemophilus influenzae (8.5%). The hospital mortality rate was statistically greater among patients with
HCAP than among those with CAP (24.6% versus 9.1%; P < 0.001). Administration of inappropriate initial
antimicrobial treatment was statistically more common among HCAP patients (28.3% versus 13.0%; P < 0.001)
and was identified as an independent risk factor for hospital mortality. Our study found that the incidence of
HCAP was greater than that of CAP among patients with culture-positive pneumonia requiring hospitalization
at Barnes-Jewish Hospital. Patients with HCAP were more likely to initially receive inappropriate antimicrobial treatment and had a greater risk of hospital mortality. Health care providers should differentiate patients
with HCAP from those with CAP in order to provide more appropriate initial antimicrobial therapy.
The relative incidences of CAP and HCAP among patients
admitted to the hospital setting for pneumonia have not previously been systematically evaluated. Therefore, we performed a study with two goals. Our first goal was to determine
the relative incidences of culture-positive CAP and HCAP in
an urban teaching hospital. The second goal of this study was
to examine the pathogens associated with culture-positive CAP
and HCAP and the relative numbers of occurrences of inappropriate initial antimicrobial treatment.

Pneumonia developing outside of the hospital setting has
traditionally been classified as community-acquired pneumonia (CAP). Nosocomial pneumonia refers to infections acquired during hospitalization and has been further differentiated into ventilator-associated pneumonia if pneumonia
developed during the course of mechanical ventilation and
hospital-acquired pneumonia if infection was not associated
with mechanical ventilation (5). Health care-associated pneumonia (HCAP) is a relatively new category of nosocomial
pneumonia that refers to infections that occur prior to hospital
admission in patients with specific risk factors (immunosuppression, recent hospitalization, residence in a nursing facility,
requiring dialysis) (5, 10). Categorization as HCAP is not due
to the provision of health care per se but to exposure to
environments within which reservoirs of infection exist (e.g.,
prior hospitalization, nursing homes, dialysis clinics). Patients
with HCAP are usually infected with potentially antibioticresistant bacteria (methicillin-resistant Staphylococcus aureus,
Pseudomonas aeruginosa, Acinetobacter species), while CAP is
typically attributed to more-susceptible bacteria (Streptococcus pneumoniae, Haemophilus influenzae, Legionella species)
(10, 14).

MATERIALS AND METHODS
Study design. A retrospective cohort analysis of all culture-positive patients
admitted to Barnes-Jewish Hospital (a 1,200-bed urban teaching hospital) with a
diagnosis of pneumonia between 1 January 2003 and 31 December 2005 was
performed.
Data source. One of the investigators (R. M. Reichley) identified all study
patients by the presence of either a primary or secondary International Classification of Diseases, Ninth Revision, Clinical Modification code indicative of
pneumonia and a concomitant positive respiratory bacterial culture, blood culture, or urine antigen test specific for Legionella pneumophila serogroup 1. The
study database was constructed by merging patient-specific data from the automated hospital records, microbiology database, and pharmacy database of Barnes-Jewish Hospital.
Definitions. CAP was defined as a diagnosis of pneumonia in patients who did
not meet any of the criteria for HCAP. The clinical diagnoses of CAP and HCAP
had to be established within 48 h of hospitalization so that confirmatory respiratory cultures were obtained. Two of the following clinical criteria were required: fever (⬎38.3°C) or hypothermia (ⱕ36.0°C), leukocytosis (⬎10 ⫻ 109
cells/liter) or leukopenia (ⱕ4 ⫻ 109 cells/liter), or purulent tracheal aspirate or
sputum. HCAP was defined as a diagnosis of pneumonia in patients admitted to
the hospital who met at least one of the following criteria: (1) admission from a
nursing home, rehabilitation hospital, or other long-term nursing care facility; (2)

* Corresponding author. Mailing address: Division of Pulmonary
and Critical Care Medicine, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8052, St. Louis, MO
63110. Phone: (314) 454-8764. Fax: (314) 454-5571. E-mail: mkollef
@im.wustl.edu.
䌤
Published ahead of print on 6 August 2007.
3568

Downloaded from http://aac.asm.org/ on March 8, 2014 by Washington University in St. Louis

Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, Missouri1; Pulmonary and Critical Care Division,
Washington University School of Medicine, St. Louis, Missouri2; and BJC Health Care, Center for
Health Care Quality and Effectiveness, St. Louis, Missouri3

VOL. 51, 2007

HEALTH CARE-ASSOCIATED AND COMMUNITY-ACQUIRED PNEUMONIA

RESULTS
Patient characteristics. A total of 639 culture-positive patients with pneumonia were admitted to Barnes-Jewish Hospital during the study period. The mean age of the population
was 58.9 ⫾ 18.1 (range, 17 to 102); there were 356 (55.7%)
males and 283 (44.3%) females. There were 431 (67.4%) patients classified as having HCAP and 208 (32.6%) with CAP.
The characteristics of the patients with HCAP and CAP are
provided in Table 1. Hospitalization during the previous 12
months was the most common criterion for HCAP. Most patients meeting the criteria for HCAP were previously hospitalized within 90 days of their current admission (Table 1). Patients with HCAP were significantly more likely to require
mechanical ventilation and admission to the intensive care unit
than patients with CAP.
Pathogen distribution. The microbiologic diagnosis of pneumonia was most often established by sputum culture or tracheal aspirate culture in 450 patients (CAP, 132 [63.5%] versus

TABLE 1. Patient characteristicsa
No. (%) of patients with
indicated infection
P value

Characteristic

Age (yr)
Sex
Male
Female
Race
White
Black
Other
HCAP criteria
Recent hospitalization
Within 90 days
⬎90 days and ⱕ180 days
⬎180 days and ⱕ1 year
Immunosuppression
Nursing home resident
Hemodialysis
Bacteremia
ICU admissionb
Mechanical ventilation
a
b

CAP
(n ⫽ 208)

HCAP
(n ⫽ 431)

57.0 ⫾ 16.9

59.8 ⫾ 18.5

0.072

121 (58.2)
87 (42.8)

235 (54.8)
196 (46.2)

0.418

100 (48)
106 (51)
2 (1)

273 (63.3)
158 (36.7)
0

⬍0.001

78 (37.5)
77 (37.0)
65 (31.3)

402 (93.3)
297 (68.9)
87 (20.2)
18 (4.2)
169 (39.2)
121 (28.1)
43 (10.0)
133 (30.9)
210 (48.7)
192 (44.5)

0.094
0.005
0.001

Values are presented as means ⫾ standard deviations.
ICU, intensive care unit.

HCAP, 318 [73.8%]), blood cultures in 211 patients (CAP, 78
[37.5%] versus HCAP, 133 [30.9%]), bronchoalveolar lavage
fluid cultures in 30 patients (CAP, 9 [4.3%] versus HCAP, 21
[4.9%]), and a positive urine antigen for Legionella pneumophila serogroup 1 in 8 patients (CAP, 7 [3.4%] versus HCAP,
1 [0.2%]).
The distributions of pathogens for CAP and HCAP are
provided in Table 2. Methicillin-resistant Staphylococcus aureus was the most common pathogen. Patients with HCAP
were significantly more likely to be infected with methicillinresistant Staphylococcus aureus, Pseudomonas aeruginosa,
other nonfermenting gram-negative rods, and other Enterobacteriaceae than patients with CAP. HCAP patients were
significantly less likely to be infected with Streptococcus
pneumoniae, Haemophilus species, and Legionella pneumophila serogroup 1 than patients with CAP. For patients
classified as having HCAP based on a prior hospitalization,
the distributions of bacterial pathogens isolated from the
respiratory tracts were similar, favoring nosocomial pathogens regardless of the timing of the previous hospitalization
(ⱕ90 days, ⬎90 days and ⱕ180 days, ⬎180 days and ⱕ1
year). The community phenotype of methicillin-resistant
Staphylococcus aureus was not significantly different for
methicillin-resistant Staphylococcus aureus isolates from patients with CAP than for those with HCAP ([9 of 25] 36%
versus [30 of 132] 23%; P ⫽ 0.153).
Secondary bacteremia occurred in 211 (33.0%) patients. The
incidence of secondary bacteremia was not significantly different among patients with CAP than for those with HCAP
(37.5% versus 30.9%; P ⫽ 0.094). The percentages of secondary bacteremia among patients with the various pathogens are
provided in Table 2.
Appropriate antimicrobial treatment. Appropriate initial
antimicrobial treatment was administered to 490 (76.7%) pa-
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previous hospitalization within the immediately preceding 12 months; (3) receiving outpatient hemodialysis, peritoneal dialysis, or infusion therapy necessitating
regular visits to a hospital-based clinic; or (4) having an immunocompromised
state. This definition for HCAP was based on our prior experience with health
care-associated infections (10, 16, 18).
The diagnosis of pneumonia was verified by one of the investigators (M. H.
Kollef or K. E. Kollef) from the medical records and required the presence of a
new radiographic infiltrate plus at least two of the following: (1) a white blood
cell count of greater than 10,000 ⫻ 103/ml; (2) a temperature of ⱖ38.3°C; (3)
purulent secretions from the lower respiratory tract; or (4) a ratio of the partial
pressure of arterial oxygen to the inspired fraction of oxygen (PaO2/FiO2) of less
than 300. Acceptable positive culture specimens included sputum, tracheal aspirate, bronchoscopic or blind bronchoalveolar lavage fluid, or blood. Blood
cultures were accepted if the same microorganism was identified in a respiratory
specimen and no other source for the positive blood culture could be identified.
Additionally, a positive urine antigen for Legionella species qualified as a culturepositive specimen.
Antimicrobial treatment was classified as being inappropriate if the initially
prescribed antibiotics were not active against the identified pathogens based on
in vitro susceptibility testing. Appropriate antimicrobial treatment had to be
prescribed within 24 h of hospital admission. The antimicrobial regimens employed at Barnes-Jewish Hospital for the treatment of suspected communityacquired pneumonia are ceftriaxone plus azithromycin or moxifloxacin monotherapy. All antimicrobial agents prescribed for CAP and HCAP, as well as for
other infections at Barnes-Jewish Hospital, are also administered at adequate
doses and intervals of administration, as monitored by the pharmacy department
and as described previously (5–7, 9, 16). The community phenotype of methicillin-resistant Staphylococcus aureus was defined as isolates resistant to methicillin
but sensitive to three or more of the following antibiotics: gentamicin, ciprofloxacin, trimethoprim-sulfamethoxazole, and clindamycin.
The definition of immunosuppression included the following: (1) daily administration of corticosteroids (at least 5 mg per day of prednisone or an equivalent
drug), (2) seropositivity for human immunodeficiency virus, (3) having received
either a solid organ transplant or bone marrow transplant, (4) treated with
radiation therapy or chemotherapy for an underlying malignancy during the 6
months prior to hospital admission, and (5) having an underlying acquired
immune deficiency disorder (hypogammaglobulinemia, combined variable immunodeficiency).
Data analysis. All comparisons were unpaired, and all tests of significance
were two tailed. Continuous variables were compared, using the Student t test
for normally distributed variables and the Mann-Whitney U test for nonnormally distributed variables. The chi-square or Fisher’s exact test was used
to compare categorical variables. We performed multiple logistic-regression
analysis using SPSS software, version 11.0, for Windows (SPSS, Inc., Chicago,
IL). Multivariate analysis was performed using models that were judged a
priori to be clinically sound. This was prospectively determined to be necessary to avoid producing spuriously significant results with multiple comparisons. All potential risk factors significant at the 0.2 level in univariate analyses
were entered into the model.
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TABLE 2. Pathogen distribution

Pathogen

a
b
c

% of patients with
bacteremia

157 (24.6)
130 (20.3)
120 (18.8)
88 (13.8)
54 (8.5)
46 (7.2)
44 (6.9)
35 (5.5)
30 (4.7)
8 (1.3)

30.6
53.1
15.8
23.9
5.6
21.3
29.5
34.3
60.0
0

No. (%) of patients with
indicated infection
CAP (n ⫽ 208)

HCAP (n ⫽ 431)

25 (12.0)
85 (40.9)
10 (4.8)
28 (13.5)
36 (17.3)
4 (1.9)
5 (2.4)
7 (3.4)
12 (5.8)
7 (3.4)

132 (30.6)
45 (10.4)
110 (25.5)
60 (13.9)
18 (4.2)
43 (10.0)
39 (9.0)
28 (6.5)
18 (4.2)
1 (0.2)

P value

⬍0.001
⬍0.001
⬍0.001
0.874
⬍0.001
⬍0.001
0.002
0.103
0.372
0.017

Acinetobacter species, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, Burkholderia species.
Enterobacter species, Citrobacter species, Serratia marcescens, Proteus species, Morganella species.
MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus.

tients within 24 h of hospital admission, and 149 (23.3%) patients received inappropriate initial antimicrobial treatment.
Patients with HCAP were statistically more likely to receive
inappropriate antimicrobial treatment than patients with CAP
(28.3% versus 13.0%; P ⬍ 0.001). Figure 1 provides the rates
of inappropriate treatment by pathogen distribution. Methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa,
other nonfermenting gram-negative rods, and other Enterobacteriaceae were the most common pathogens to be initially
treated with an inappropriate antimicrobial regimen. Of the
220 patients initially treated only with a community-acquiredpneumonia antimicrobial regimen (ceftriaxone plus azithromycin or moxifloxacin), 49 (22.3%) initially received inappropriate antimicrobial treatment (CAP, 15 [13.6%] versus HCAP,
34 [30.9%]; P ⫽ 0.002).

Hospital mortality rates. The overall hospital mortality
rate was 19.6% (125 patients expired during their hospital
stays). Patients with HCAP were significantly more likely to
die than patients with CAP (24.6% versus 9.1%; P ⬍ 0.001).
Similarly, patients treated with an inappropriate initial antimicrobial regimen had a greater rate of hospital mortality
than patients treated with an appropriate initial regimen
(32.2% versus 15.7%; P ⬍ 0.001). Logistic-regression analysis identified seven variables as independent predictors of
hospital mortality (Table 3). Administration of inappropriate initial antimicrobial treatment was independently associated with hospital mortality. Figure 2 shows the hospital
mortality rate for patients infected with the pathogens associated with culture-positive pneumonia. Methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, Esch-

FIG. 1. Rates of inappropriate antimicrobial treatment in patients according to pathogen distribution. GNR, gram-negative rods.
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MRSAc
Streptococcus pneumoniae
Pseudomonas aeruginosa
MSSAc
Haemophilus species
Other nonfermenting gram-negative rodsa
Other Enterobacteriaceaeb
Klebsiella species
Escherichia coli
Legionella species

No. (%) of patients with a
combination of infections
(n ⫽ 639)
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TABLE 3. Multivariate analysis of independent risk factors for
hospital mortalitya
Variable

95% CIb

P value

1.02
2.28
5.05
2.19

1.01–1.04
1.67–3.13
3.68–6.92
1.27–3.78

0.001
0.009
⬍0.001
0.005

3.26
1.80
2.53

2.54–4.82
1.12–2.89
1.66–3.91

⬍0.001
0.015
0.034

a
Other covariates not presented in the table that had a P value of ⬎0.05 are
intensive care unit admission; monotherapy antibiotic regimen; or infection with
methicillin-resistant Staphylococus aureus, Pseudomonas aerginosa, Streptococcus
pneumoniae, or methicillin-sensitive Staphylococcus aureus. By the HosmerLemeshow goodness-of-fit test, P ⫽ 0.653.
b
CI, confidence interval.

erichia coli, Klebsiella species, and other nonfermenting
gram-negative rods were associated with a hospital mortality
rate greater then 20 percent.
DISCUSSION
We showed that in an urban teaching hospital, HCAP was
more common than CAP among patients admitted with a culture-positive diagnosis of pneumonia. Methicillin-resistant
Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas aeruginosa, methicillin-sensitive Staphylococcus aureus, and
Haemophilus influenzae were the most common pathogens associated with culture-positive pneumonia. HCAP patients
were statistically more likely to be infected with methicillin-

resistant Staphylococcus aureus, Pseudomonas aeruginosa,
other nonfermenting gram-negative rods, and other Enterobacteriaceae and were significantly more likely to receive inappropriate initial antimicrobial treatment than patients with CAP.
Patients receiving inappropriate initial antimicrobial treatment
were significantly more likely to die during their hospitalizations than patients treated with an appropriate initial antimicrobial regimen.
Previous investigations have shown that antimicrobial regimens lacking activity against identified microorganisms
causing serious infections (e.g., nosocomial pneumonia,
bloodstream infections) are associated with greater rates of
hospital mortality (1, 3, 6, 7–11, 13, 15, 17). In these studies,
inappropriate initial antimicrobial treatment was most often
associated with infection due to potentially antibiotic-resistant bacteria (methicillin-resistant Staphylococcus aureus,
Pseudomonas aeruginosa, Acinetobacter species). More recently, a similar finding has been demonstrated for patients
with severe sepsis and septic shock (2, 4, 12, 16). Unfortunately, changing antimicrobial therapy to an appropriate
regimen for patients with serious nosocomial infections, including pneumonia, after susceptibility data become available has not been demonstrated to improve clinical outcomes in patients initially receiving inappropriate treatment
(1, 11, 13). Our present findings are consistent with these
previous studies in demonstrating that potentially antibioticresistant pathogens (Pseudomonas aeruginosa, methicillinresistant Staphylococcus aureus, other nonfermenting gramnegative rods, and other Enterobactereacae) were significantly
more likely to occur in patients with HCAP and to be
treated with an inappropriate antibiotic regimen and that

FIG. 2. Rates of hospital mortality according to pathogen distribution. GNR, gram-negative rods.
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Age (1-yr increments)
HCAP
Requires mechanical ventilation
Inappropriate initial antimicrobial
therapy
Bacteremia
Caucasian
Klebsiella species infection

Adjusted
odds ratio
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associated with a significant reduction in hospital mortality
(16). The standardized order set required physicians to screen
patients for health care-associated infection risk factors and to
treat with a combination antimicrobial regimen targeting
methicillin-resistant Staphylococcus aureus and potentially resistant gram-negative bacteria when these risk factors were
identified. A similar study by Ibrahim et al. found that a treatment protocol for the management of ventilator-associated
pneumonia increased the administration of initial appropriate
antimicrobial therapy employing a combination antimicrobial
regimen (7). Implementation of standardized approaches for
the treatment of HCAP and other health care-associated infections seems reasonable, since failure to identify risk factors
for health care-associated infections appears to be the most
common cause for the administration of inappropriate antimicrobial therapy to patients hospitalized with serious infections (16, 18).
In summary, we found that HCAP was more common than
CAP among patients with culture-positive pneumonia admitted to an urban teaching hospital. Patients with HCAP were
more likely to receive inappropriate initial antimicrobial treatment and had a greater risk of hospital mortality. Clinicians
caring for patients with pneumonia requiring hospital admission should be aware of the risk factors for HCAP and the
predominant bacterial pathogens associated with health careassociated infections at their hospitals. Awareness of these
issues may result in improved rates of initial administration of
appropriate antimicrobial treatment to patients with HCAP.
Additionally, new studies are required to develop uniform and
validated criteria for HCAP and other health care-associated
infections.
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